Proteostasis Therapeutics, Inc. (PTI)

Proteostasis Therapeutics, Inc. (PTI) Company Bio

Proteostasis Therapeutics, Inc., a biopharmaceutical company, develops therapeutics to treat protein conformational diseases. The company offers disease-modifying therapeutics for cystic fibrosis; and also develops treatments for diseases caused by an imbalance in the proteostasis network and characterized by defects in protein folding, trafficking, and clearance, including genetic, neurodegenerative, and retinal degenerative diseases. The company was founded in 2006 and is based in Cambridge, Massachusetts.

PTI Daily Price Range
PTI 52-Week Price Range
Add PTI to Watchlist
Sign Up

PTI - Live POWR Rating™

Overall POWR Rating

To view PTI's real-time POWR Rating, sign up now.

Access Ratings for Free

PTI News Stream

Event/Time News Detail Start End Change
Loading, please wait...
View All PTI News
The Top Stocks For 2019

PTI Stock Chart More Charts

PTI Price/Volume Stats

Current price $4.80
Prev. close $4.88
Day low $4.72
Day high $4.93
50-day MA $5.20
200-day MA $4.07
52-week high $10.38
52-week low $1.71
Volume 157,421
Avg. volume 1,525,090
Dividend yield N/A
Market Cap 176.16M

PTI Social Stream

Loading social stream, please wait...

View Full PTI Social Stream

PTI Returns

1-mo -21.70%
3-mo 113.33%
6-mo 50.47%
1-year 2.35%
3-year N/A
5-year N/A
YTD -17.67%
2017 -52.45%
2016 N/A
2015 N/A
2014 N/A
2013 N/A
Page generated in 0.2927 seconds.